{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:35:35Z","timestamp":1770773735470,"version":"3.50.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T00:00:00Z","timestamp":1558915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T00:00:00Z","timestamp":1558915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s10741-019-09805-1","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T06:06:27Z","timestamp":1558937187000},"page":"977-987","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cardio-oncology, the myth of Sisyphus, and cardiovascular disease in breast cancer survivors"],"prefix":"10.1007","volume":"24","author":[{"given":"Sophie I.","family":"Mavrogeni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Sfendouraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Markousis-Mavrogenis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelos","family":"Rigopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Noutsias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genovefa","family":"Kolovou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantina","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Tousoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,27]]},"reference":[{"issue":"8","key":"9805_CR1","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1161\/CIR.0000000000000556","volume":"137","author":"LS Mehta","year":"2018","unstructured":"Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, Dent S, Kondapalli L, Ky B, Okwuosa T, Pi\u00f1a IL, Volgman AS, American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Quality of Care and Outcomes Research (2018) Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation 137(8):e30\u2013e66","journal-title":"Circulation"},{"issue":"7","key":"9805_CR2","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jacc.2018.11.046","volume":"73","author":"C Gal\u00e1n-Arriola","year":"2019","unstructured":"Gal\u00e1n-Arriola C, Lobo M, V\u00edlchez-Tschischke JP, L\u00f3pez GJ, de Molina-Iracheta A, P\u00e9rez-Mart\u00ednez C, Ag\u00fcero J, Fern\u00e1ndez-Jim\u00e9nez R, Mart\u00edn-Garc\u00eda A, Oliver E, Villena-Gutierrez R, Pizarro G, S\u00e1nchez PL, Fuster V, S\u00e1nchez-Gonz\u00e1lez J, Ibanez B (2019) Serial magnetic resonance imaging to identify early stages of anthracycline-induced cardiotoxicity. J Am Coll Cardiol 73(7):779\u2013791","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"9805_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000265166","volume":"115","author":"K Chatterjee","year":"2010","unstructured":"Chatterjee K, Zhang J, Honbo N, Karliner JS (2010) Doxorubicin cardiomyopathy. Cardiology. 115(2):155\u2013162","journal-title":"Cardiology."},{"issue":"6","key":"9805_CR4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s10741-017-9641-4","volume":"22","author":"JG Westphal","year":"2017","unstructured":"Westphal JG, Rigopoulos AG, Bakogiannis C, Ludwig SE, Mavrogeni S, Bigalke B, Doenst T, Pauschinger M, Tsch\u00f6pe C, Schulze PC, Noutsias M (2017) The MOGE(S) classification for cardiomyopathies: current status and future outlook. Heart Fail Rev 22(6):743\u2013752","journal-title":"Heart Fail Rev"},{"key":"9805_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.radonc.2012.02.008","volume":"103","author":"A Sardaro","year":"2012","unstructured":"Sardaro A, Petruzzelli MF, D'Errico MP, Grimaldi L, Pili G, Portaluri M (2012) Radiation-induced cardiac damage in early left breast cancer patients: risk factors, biological mechanisms, radiobiology, and dosimetric constraints. Radiother Oncol 103:133\u2013142","journal-title":"Radiother Oncol"},{"key":"9805_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ijcard.2017.03.136","volume":"241","author":"D Lenihan","year":"2017","unstructured":"Lenihan D (2017) Cardio-oncology: what is the best practice we can all strivre for? Int J Cardiol 241:393\u2013394","journal-title":"Int J Cardiol"},{"key":"9805_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/ejhf.654","volume":"19","author":"JL Zamorano","year":"2017","unstructured":"Zamorano JL, Lancellotti P, Rodriguez Mu\u00f1oz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GYH, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM, Zamorano JL, Aboyans V, Achenbach S, Agewall S, Badimon L, Bar\u00f3n-Esquivias G, Baumgartner H, Bax JJ, Bueno H, Carerj S, Dean V, Erol \u00c7, Fitzsimons D, Gaemperli O, Kirchhof P, Kolh P, Lancellotti P, Lip GYH, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Roffi M, Torbicki A, Vaz Carneiro A, Windecker S, Authors\/Task Force Members, ESC Committee for Practice Guidelines (CPG), Document Reviewers (2017) 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur J Heart Fail 19:9\u201342","journal-title":"Eur J Heart Fail"},{"key":"9805_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4081\/oncol.2017.340","volume":"11","author":"MG Fradley","year":"2017","unstructured":"Fradley MG, Brown AC, Shields B et al (2017) Developing a comprehensive cardio-oncology program at a cancer institute: the Moffit cancer center experience. Oncol Rev 11:340","journal-title":"Oncol Rev"},{"key":"9805_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40959-016-0014-2","volume":"2","author":"S Barros-Gomez","year":"2016","unstructured":"Barros-Gomez S, Herrmann J, Mulvagh SL et al (2016) Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic. Cardio-Oncology 2:5","journal-title":"Cardio-Oncology"},{"key":"9805_CR10","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1016\/j.jacc.2015.04.059","volume":"65","author":"A Barac","year":"2015","unstructured":"Barac A, Murthag G, Carver JR et al (2015) Cardiovascular health of patients with cancer and cancer survivors. J Am Coll Cardiol 65:2739\u20132746","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"9805_CR11","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3816\/CBC.2007.n.028","volume":"7","author":"E Andreopoulou","year":"2007","unstructured":"Andreopoulou E, Gaiotti D, Kim E, Volm M, Oratz R, Freedberg R, Downey A, Vogel CL, Chia S, Muggia F (2007) Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancer. Clin Breast Cancer 7(9):690\u2013696","journal-title":"Clin Breast Cancer"},{"key":"9805_CR12","doi-asserted-by":"publisher","first-page":"e002843","DOI":"10.1161\/CIRCHEARTFAILURE.115.002843","volume":"9","author":"CE Hamo","year":"2016","unstructured":"Hamo CE, Bloom MW, Cardinale D et al (2016) Cancer therapy-related cardiac dysfunction and heart failure: part 2: prevention, treatment, guidelines, and future directions. Circ Heart Fail 9:e002843","journal-title":"Circ Heart Fail"},{"key":"9805_CR13","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1200\/JCO.2016.67.4846","volume":"34","author":"C Guenancia","year":"2016","unstructured":"Guenancia C, Lefevbvre A, Cardinale D et al (2016) Obesity as a risk factor for anthracyclines and trastuzumab cardiotoxicity in breast cancer: a systematic review and meta-analysis. J Clin Oncol 34:3157\u20133165","journal-title":"J Clin Oncol"},{"key":"9805_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.clinbiochem.2014.10.013","volume":"48","author":"ES Christenson","year":"2015","unstructured":"Christenson ES, James T, Agrawal V, Park BH (2015) Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity. Clin Biochem 48:223\u2013235","journal-title":"Clin Biochem"},{"key":"9805_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/14737159.2017.1283219","volume":"17","author":"D Cardinale","year":"2017","unstructured":"Cardinale D, Biasillo G, Salvatici M, Sandri MT, Cipolla CM (2017) Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy. Expert Rev Mol Diagn 17:245\u2013256","journal-title":"Expert Rev Mol Diagn"},{"key":"9805_CR16","first-page":"691","volume":"6","author":"MA Daubert","year":"2010","unstructured":"Daubert MA, Jeremias A (2010) The utility of troponin measurement to detect myocardial infarction: review of the current findings. Vasc Health Risk Manag 6:691\u2013699","journal-title":"Vasc Health Risk Manag"},{"key":"9805_CR17","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1161\/01.CIR.96.8.2641","volume":"96","author":"SE Lipshultz","year":"1997","unstructured":"Lipshultz SE, Rifai N, Sallan SE, Lipsitz SR, Dalton V, Sacks DB, Ottlinger ME (1997) Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation 96:2641\u20132648","journal-title":"Circulation"},{"key":"9805_CR18","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/annonc\/mdf170","volume":"13","author":"D Cardinale","year":"2002","unstructured":"Cardinale D, Sandri MT, Martinoni A, Borghini E, Civelli M, Lamantia G, Cinieri S, Martinelli G, Fiorentini C, Cipolla CM (2002) Myocardial injury revealed by plasma troponin I in breast cancer treatment with high dose chemotherapy. Ann Oncol 13:710\u2013715","journal-title":"Ann Oncol"},{"key":"9805_CR19","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1161\/01.CIR.0000130926.51766.CC","volume":"109","author":"D Cardinale","year":"2004","unstructured":"Cardinale D, Sandri MT, Colombo A, Colombo N, Boeri M, Lamantia G, Civelli M, Peccatori F, Martinelli G, Fiorentini C, Cipolla CM (2004) Prognostic value of Troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. Circulation 109:2749\u20132754","journal-title":"Circulation"},{"key":"9805_CR20","doi-asserted-by":"publisher","first-page":"3910","DOI":"10.1200\/JCO.2009.27.3615","volume":"28","author":"D Cardinale","year":"2010","unstructured":"Cardinale D, Colombo A, Torrisi R, Sandri MT, Civelli M, Salvatici M, Lamantia G, Colombo N, Cortinovis S, Dessanai MA, Nol\u00e8 F, Veglia F, Cipolla CM (2010) Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of Troponin I evaluation. J Clin Oncol 28:3910\u20133916","journal-title":"J Clin Oncol"},{"issue":"6","key":"9805_CR21","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s12282-017-0778-8","volume":"24","author":"H Kitayama","year":"2017","unstructured":"Kitayama H, Kondo T, Sugiyama J, Kurimoto K, Nishino Y, Kawada M, Hirayama M, Tsuji Y (2017) High-sensitive troponin T assay can predict anthracycline- and trastuzumab-induced cardiotoxicity in breast cancer patients. Breast Cancer 24(6):774\u2013782","journal-title":"Breast Cancer"},{"key":"9805_CR22","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","volume":"35","author":"SH Armenian","year":"2017","unstructured":"Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, Dent S, Douglas PS, Durand JB, Ewer M, Fabian C, Hudson M, Jessup M, Jones LW, Ky B, Mayer EL, Moslehi J, Oeffinger K, Ray K, Ruddy K, Lenihan D (2017) Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 35:893\u2013911","journal-title":"J Clin Oncol"},{"key":"9805_CR23","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1080\/14779072.2016.1239528","volume":"14","author":"D Cardinale","year":"2016","unstructured":"Cardinale D, Cipolla CM (2016) Chemotherapy-induced cardiotoxicity: importance of early detection. Expert Rev Cardiovasc Ther 14:1297\u20131299","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"9805_CR24","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","volume":"131","author":"D Cardinale","year":"2015","unstructured":"Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F, Civelli M, Lamantia G, Colombo N, Curigliano G, Fiorentini C, Cipolla CM (2015) Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation 131:1981\u20131988","journal-title":"Circulation"},{"issue":"1","key":"9805_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12094-016-1508-y","volume":"19","author":"J Gavila","year":"2017","unstructured":"Gavila J, Segu\u00ed M\u00c1, Calvo L, L\u00f3pez T, Alonso JJ, Farto M, S\u00e1nchez-de la Rosa R (2017) Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study. Clin Transl Oncol 19(1):91\u2013104","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"9805_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/eurheartj\/ehn484","volume":"30","author":"C Jenkins","year":"2009","unstructured":"Jenkins C, Moir S, Chan J, Rakhit D, Haluska B, Marwick TH (2009) Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging. Eur Heart J 30(1):98\u2013106","journal-title":"Eur Heart J"},{"key":"9805_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijcard.2015.06.052","volume":"198","author":"C Aggeli","year":"2015","unstructured":"Aggeli C, Felekos I, Kastellanos S, Panagopoulou V, Oikonomou E, Tsiamis E, Tousoulis D (2015) Real-time three-dimensional echocardiography: never before clinical efficacy looked so picturesque. Int J Cardiol 198:15\u201321","journal-title":"Int J Cardiol"},{"issue":"20","key":"9805_CR28","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.jacc.2012.01.037","volume":"59","author":"JL Dorosz","year":"2012","unstructured":"Dorosz JL, Lezotte DC, Weitzenkamp DA, Allen LA, Salcedo EE (2012) Performance of 3-dimensional echocardiography in measuring left ventricular volumes and ejection fraction: a systematic review and meta-analysis. J Am Coll Cardiol 59(20):1799\u20131808","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"9805_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/PRS.0b013e31829e7bec","volume":"132","author":"M Pignatti","year":"2013","unstructured":"Pignatti M, Mantovani F, Bertelli L, Barbieri A, Pacchioni L, Loschi P, De Santis G (2013) Effects of silicone expanders and implants on echocardiographic image quality after breast reconstruction. Plast Reconstr Surg 132(2):271\u2013278","journal-title":"Plast Reconstr Surg"},{"issue":"12","key":"9805_CR30","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.echo.2008.10.005","volume":"21","author":"R Jurcut","year":"2008","unstructured":"Jurcut R, Wildiers H, Ganame J, D'hooge J, De Backer J, Denys H, Paridaens R, Rademakers F, Voigt JU (2008) Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer. J Am Soc Echocardiogr 21(12):1283\u20131289","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"9805_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10554-007-9286-9","volume":"24","author":"H Pavlopoulos","year":"2008","unstructured":"Pavlopoulos H, Nihoyannopoulos P (2008) Strain and strain rate deformation parameters: from tissue Doppler to 2D speckle tracking. Int J Cardiovasc Imaging. 24(5):479\u2013491","journal-title":"Int J Cardiovasc Imaging."},{"issue":"3","key":"9805_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/ejechocard\/jer021","volume":"12","author":"V Mor-Avi","year":"2011","unstructured":"Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, Galderisi M, Marwick T, Nagueh SF, Sengupta PP, Sicari R, Smiseth OA, Smulevitz B, Takeuchi M, Thomas JD, Vannan M, Voigt JU, Zamorano JL (2011) Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE\/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocardiogr 12(3):167\u2013205","journal-title":"Eur J Echocardiogr"},{"issue":"10","key":"9805_CR33","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.amjcard.2018.08.019","volume":"122","author":"M Laufer-Perl","year":"2018","unstructured":"Laufer-Perl M, Derakhshesh M, Milwidsky A, Mor L, Ravid D, Amrami N, Sherez J, Keren G, Topilsky Y, Arbel Y (2018) Usefulness of global longitudinal strain for early identification of subclinical left ventricular dysfunction in patients with active cancer. Am J Cardiol 122(10):1784\u20131789","journal-title":"Am J Cardiol"},{"issue":"22","key":"9805_CR34","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.jacc.2010.11.063","volume":"57","author":"N Fallah-Rad","year":"2011","unstructured":"Fallah-Rad N, Walker JR, Wassef A, Lytwyn M, Bohonis S, Fang T, Tian G, Kirkpatrick ID, Singal PK, Krahn M, Grenier D, Jassal DS (2011) The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coll Cardiol 57(22):2263\u20132270","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"9805_CR35","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s11739-017-1741-6","volume":"12","author":"G Galanti","year":"2017","unstructured":"Galanti G, Pedrizzetti G, Pedri S, Stefani L (2017) 2D longitudinal LV speckle tracking strain pattern in breast cancer survivors: sports activity vs exercise as prescription model. Intern Emerg Med 12(8):1149\u20131157","journal-title":"Intern Emerg Med"},{"issue":"25 Pt A","key":"9805_CR36","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","volume":"63","author":"P Thavendiranathan","year":"2014","unstructured":"Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH (2014) Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol 63(25 Pt A):2751\u20132768","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"9805_CR37","first-page":"977","volume":"16","author":"N Mousavi","year":"2015","unstructured":"Mousavi N, Tan TC, Ali M, Halpern EF, Wang L, Scherrer-Crosbie M (2015) Echocardiographic parameters of left ventricular size and function as predictors of symptomatic heart failure in patients with a left ventricular ejection fraction of 50-59% treated with anthracyclines. Eur Heart J Cardiovasc Imaging 16(9):977\u2013984","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"9805_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/ejechocard\/jer172","volume":"13","author":"H Motoki","year":"2012","unstructured":"Motoki H, Koyama J, Nakazawa H, Aizawa K, Kasai H, Izawa A, Tomita T, Miyashita Y, Kumazaki S, Takahashi M, Ikeda U (2012) Torsion analysis in the early detection of anthracycline-mediated cardiomyopathy. Eur Heart J Cardiovasc Imaging 13(1):95\u2013103","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"9805_CR39","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10554-018-1510-2","volume":"35","author":"Y Xu","year":"2019","unstructured":"Xu Y, Shi J, Zhao R, Zhang C, He Y, Lin J, Zhang Q, Shu X, Cheng L (2019) Anthracycline induced inconsistent left ventricular segmental systolic function variation in patients with lymphoma detected by three-dimensional speckle tracking imaging. Int J Cardiovasc Imaging 35:771\u2013779. https:\/\/doi.org\/10.1007\/s10554-018-1510-2","journal-title":"Int J Cardiovasc Imaging"},{"issue":"2","key":"9805_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.15420\/ecr.2018.19.1","volume":"13","author":"SI Mavrogeni","year":"2018","unstructured":"Mavrogeni SI, Markousis-Mavrogenis G, Kolovou G (2018) \u201cSave the last dance\u201d for cardiovascular magnetic resonance. Eur Cardiol 13(2):95\u201397","journal-title":"Eur Cardiol"},{"key":"9805_CR41","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1067\/mhj.2001.115436","volume":"141","author":"R Wassmuth","year":"2001","unstructured":"Wassmuth R, Lentzsch S, Erdbruegger U, Schulz-Menger J, Doerken B, Dietz R, Friedrich MG (2001) Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging\u2014a pilot study. Am Heart J 141:1007\u20131013","journal-title":"Am Heart J"},{"key":"9805_CR42","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.jcmg.2012.11.017","volume":"6","author":"BC Drafts","year":"2013","unstructured":"Drafts BC, Twomley KM, D\u2019Agostino R Jr et al (2013) Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease. J Am Coll Cardiol Img 6:877\u2013885","journal-title":"J Am Coll Cardiol Img"},{"key":"9805_CR43","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1053\/euhj.2000.2011","volume":"21","author":"N Bellenger","year":"2000","unstructured":"Bellenger N, Burgess M, Ray S, Lahiri A, Coats AJ, Cleland JG, Pennell DJ (2000) Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance. Are they interchangeable? Eur Heart J 21:1387\u20131396","journal-title":"Eur Heart J"},{"key":"9805_CR44","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1200\/JCO.2016.70.0229","volume":"35","author":"K Wang","year":"2017","unstructured":"Wang K, Eblan MJ, Deal AM, Lipner M, Zagar TM, Wang Y, Mavroidis P, Lee CB, Jensen BC, Rosenman JG, Socinski MA, Stinchcombe TE, Marks LB (2017) Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: pooled analysis of dose escalation trials delivering 70 to 90 Gy. J Clin Oncol 35:1387\u20131394","journal-title":"J Clin Oncol"},{"key":"9805_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1040-8428(01)00227-X","volume":"45","author":"MJ Adams","year":"2003","unstructured":"Adams MJ, Hardenbergh PH, Constine LS, Lipshultz SE (2003) Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol 45:55\u201375","journal-title":"Crit Rev Oncol Hematol"},{"key":"9805_CR46","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1161\/CIRCULATIONAHA.117.027740","volume":"135","author":"S Romano","year":"2017","unstructured":"Romano S, Judd RM, Kim RJ, Kim HW, Klem I, Heitner J, Shah DJ, Jue J, White BE, Shenoy C, Farzaneh-Far A (2017) Association of feature-tracking cardiac magnetic resonance imaging left ventricular global longitudinal strain with all-cause mortality in patients with reduced left ventricular ejection fraction. Circulation 135:2313\u20132315","journal-title":"Circulation"},{"key":"9805_CR47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12968-017-0373-3","volume":"19","author":"M-P Jolly","year":"2017","unstructured":"Jolly M-P, Jordan JH, Mel\u00e9ndez GC, McNeal GR, D\u2019Agostino RB, Hundley WG (2017) Auto-mated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapy. J Cardiovasc Magn Reson 19:59","journal-title":"J Cardiovasc Magn Reson"},{"key":"9805_CR48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijcard.2018.10.023","volume":"275","author":"JD Haslbauer","year":"2019","unstructured":"Haslbauer JD, Lindner S, Valbuena-Lopez S, Zainal H, Zhou H, D'Angelo T, Pathan F, Arendt CA, Bug G, Serve H, Vogl TJ, Zeiher AM, Carr-White G, Nagel E, Puntmann VO (2019) CMR imaging biosignature of cardiac involvement due to cancer-related treatment by T1 and T2 mapping. Int J Cardiol 275:179\u2013186","journal-title":"Int J Cardiol"},{"key":"9805_CR49","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.amjcard.2012.11.022","volume":"111","author":"TG Neilan","year":"2013","unstructured":"Neilan TG, Coelho OR, Shah RV et al (2013) Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy. Am J Cardiol 111:717\u2013722","journal-title":"Am J Cardiol"},{"key":"9805_CR50","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1161\/CIRCIMAGING.114.002217","volume":"7","author":"JH Jordan","year":"2014","unstructured":"Jordan JH, D\u2019Agostino RB, Hamilton CA et al (2014) Longitudinal assessment of concurrent changes in left ventricular ejection fraction and left ventricular myocardial tissue characteristics after administration of cardiotoxic chemotherapies using t1-weighted and t2-weighted cardiovascular magnetic resonance. Circ Cardiovasc Imaging 7:872\u2013879","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"9805_CR51","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000478901","volume":"138","author":"S Mavrogeni","year":"2017","unstructured":"Mavrogeni S, Apostolou D, Argyriou P, Velitsista S, Papa L, Efentakis S, Vernardos E, Kanoupaki M, Kanoupakis G, Manginas A (2017) T1 and T2 mapping in cardiology: \u201cmapping the obscure object of desire\u201d. Cardiology. 138(4):207\u2013217","journal-title":"Cardiology."},{"key":"9805_CR52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1532-429X-15-66","volume":"15","author":"S Vasu","year":"2013","unstructured":"Vasu S, Hundley WG (2013) Understanding cardio-vascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 15:66\u201383","journal-title":"J Cardiovasc Magn Reson"},{"key":"9805_CR53","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ijcard.2016.11.242","volume":"228","author":"S Mavrogeni","year":"2017","unstructured":"Mavrogeni S, Bratis K, Koutsogeorgopoulou L, Karabela G, Savropoulos E, Katsifis G, Raftakis J, Markousis-Mavrogenis G, Kolovou G (2017) Myocardial perfusion in peripheral Raynaud\u2019s phenomenon. Evaluation using stress cardiovascular magnetic resonance. Int J Cardiol 228:444\u2013448","journal-title":"Int J Cardiol"},{"key":"9805_CR54","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12968-017-0356-4","volume":"19","author":"A Barthur","year":"2017","unstructured":"Barthur A, Brezden-Masley C, Connelly KA, Dhir V, Chan KKW, Haq R, Kirpalani A, Barfett JJ, Jimenez-Juan L, Karur GR, Deva DP, Yan AT (2017) Longitudinal assessment of right ventricular structure and function by cardiovascular magnetic resonance in breast cancer patients treated with trastuzumab: a prospective observational study. J Cardiovasc Magn Reson 19:44","journal-title":"J Cardiovasc Magn Reson"},{"key":"9805_CR55","doi-asserted-by":"publisher","first-page":"e004560","DOI":"10.1161\/CIRCHEARTFAILURE.117.004560","volume":"11","author":"JH Jordan","year":"2018","unstructured":"Jordan JH, Castellino SM, Mel\u00e9ndez GC et al (2018) Left ventricular mass change after anthracycline chemotherapy. Circ Heart Fail 11:e004560","journal-title":"Circ Heart Fail"},{"key":"9805_CR56","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1064-9689(21)00179-3","volume":"4","author":"CS White","year":"1996","unstructured":"White CS (1996) MR evaluation of the pericardium and cardiac malignancies. Magn Reson Imaging Clin N Am 4:237\u2013251","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"9805_CR57","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.amjcard.2005.01.094","volume":"95","author":"M Imazio","year":"2005","unstructured":"Imazio M, Demichelis B, Parrini I, Favro E, Beqaraj F, Cecchi E, Pomari F, Demarie D, Ghisio A, Belli R, Bobbio M, Trinchero R (2005) Relation of acute pericardial disease to malignancy. Am J Cardiol 95:1393\u20131394","journal-title":"Am J Cardiol"},{"key":"9805_CR58","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.pcad.2010.06.003","volume":"53","author":"B Maisch","year":"2010","unstructured":"Maisch B, Ristic A, Pankuweit S (2010) Evaluation and management of pericardial effusion in patients with neoplastic disease. Prog Cardiovasc Dis 53:157\u2013163","journal-title":"Prog Cardiovasc Dis"},{"key":"9805_CR59","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1056\/NEJM199907293410515","volume":"341","author":"S Kojima","year":"1999","unstructured":"Kojima S, Yamada N, Goto Y (1999) Diagnosis of constrictive pericarditis by tagged cine magnetic resonance imaging. N Engl J Med 341:373\u2013374","journal-title":"N Engl J Med"},{"key":"9805_CR60","doi-asserted-by":"crossref","unstructured":"Wang ZJ, Reddy GP, Gotway MB, Yeh BM, Hetts SW, Higgins CB (2003) CT and MR imaging of pericardial disease. Radiographics 23 Spec No:S167\u2013S180","DOI":"10.1148\/rg.23si035504"},{"key":"9805_CR61","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.jcmg.2011.08.011","volume":"4","author":"AO Zurick","year":"2011","unstructured":"Zurick AO, Bolen MA, Kwon DH, Tan CD, Popovic ZB, Rajeswaran J, Rodriguez ER, Flamm SD, Klein AL (2011) Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with histopathological correlation. J Am Coll Cardiol Img 4:1180\u20131191","journal-title":"J Am Coll Cardiol Img"},{"key":"9805_CR62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1532-429X-11-14","volume":"11","author":"J Bogaert","year":"2009","unstructured":"Bogaert J, Francone M (2009) Cardiovascular magnetic resonance in pericardial diseases. J Cardiovasc Magn Reson 11:14","journal-title":"J Cardiovasc Magn Reson"},{"key":"9805_CR63","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1200\/JCO.2016.67.4887","volume":"35","author":"EA Perez","year":"2017","unstructured":"Perez EA, Barrios C, Eiermann W, Toi M, Im YH, Conte P, Martin M, Pienkowski T, Pivot X, Burris HA, Petersen JA, Stanzel S, Strasak A, Patre M, Ellis P (2017) Trastuzumab emtansine with or without pertuzumab versus trastuzumab plus taxane for human epidermal growth factor receptor 2-positive, advanced breast cancer: primary results from the phase III MARIANNE Study. J Clin Oncol 35:141\u2013148","journal-title":"J Clin Oncol"},{"key":"9805_CR64","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa035153","volume":"351","author":"SE Lipshultz","year":"2004","unstructured":"Lipshultz SE, Rifai N, Dalton VM, Levy DE, Silverman LB, Lipsitz SR, Colan SD, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Gelber RD, Sallan SE (2004) The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med 351:145\u2013153","journal-title":"N Engl J Med"},{"key":"9805_CR65","doi-asserted-by":"crossref","unstructured":"Sieswerda E, van Dalen EC, Postma A et al (2011) Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer [serial online]. Cochrane Database Syst Rev 9","DOI":"10.1002\/14651858.CD008011.pub2"},{"key":"9805_CR66","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1200\/JCO.2008.17.2627","volume":"27","author":"ML Hensley","year":"2009","unstructured":"Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH, Cohen GI, Emami B, Gradishar WJ, Mitchell RB, Thigpen JT, Trotti A III, von Hoff D, Schuchter LM (2009) American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol 27:127\u2013145","journal-title":"J Clin Oncol"},{"key":"9805_CR67","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/j.jacc.2006.07.052","volume":"48","author":"N Kalay","year":"2006","unstructured":"Kalay N, Basar E, Ozdogru I, Er O, Cetinkaya Y, Dogan A, Oguzhan A, Eryol NK, Topsakal R, Ergin A, Inanc T (2006) Protective effects of carvedilol against anthracycline-induced cardiomyopathy. J Am Coll Cardiol 48:2258\u20132262","journal-title":"J Am Coll Cardiol"},{"key":"9805_CR68","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1016\/j.ijcard.2012.06.023","volume":"167","author":"MG Kaya","year":"2013","unstructured":"Kaya MG, Ozkan M, Gunebakmaz O, Akkaya H, Kaya EG, Akpek M, Kalay N, Dikilitas M, Yarlioglues M, Karaca H, Berk V, Ardic I, Ergin A, Lam YY (2013) Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study. Int J Cardiol 167:2306\u20132310","journal-title":"Int J Cardiol"},{"key":"9805_CR69","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1161\/CIRCHEARTFAILURE.112.000055","volume":"6","author":"S Seicean","year":"2013","unstructured":"Seicean S, Seicean A, Alan N, Plana JC, Budd GT, Marwick TH (2013) Cardioprotective effect of \u03b2-adrenoceptor blockade in patients with breast cancer undergoing chemotherapy: follow-up study of heart failure. Circ Heart Fail 6:420\u2013426","journal-title":"Circ Heart Fail"},{"key":"9805_CR70","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1200\/JCO.2016.68.7830","volume":"35","author":"E Pituskin","year":"2017","unstructured":"Pituskin E, Mackey JR, Koshman S, Jassal D, Pitz M, Haykowsky MJ, Pagano JJ, Chow K, Thompson RB, Vos LJ, Ghosh S, Oudit GY, Ezekowitz JA, Paterson DI (2017) Multidisciplinary approach to novel therapies in cardio-oncology research (MANTICORE 101-breast): a randomized trial for the prevention of Trastuzumab-associated cardiotoxicity. J Clin Oncol 35:870\u2013877","journal-title":"J Clin Oncol"},{"key":"9805_CR71","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","volume":"114","author":"D Cardinale","year":"2006","unstructured":"Cardinale D, Colombo A, Sandri MT, Lamantia G, Colombo N, Civelli M, Martinelli G, Veglia F, Fiorentini C, Cipolla CM (2006) Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation 114:2474\u20132481","journal-title":"Circulation"},{"key":"9805_CR72","doi-asserted-by":"publisher","first-page":"487.e1-7","DOI":"10.1016\/j.ahj.2010.05.037","volume":"160","author":"C Cadeddu","year":"2010","unstructured":"Cadeddu C, Piras A, Mantovani G et al (2010) Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment. Am Heart J 160:487.e1-7","journal-title":"Am Heart J"},{"key":"9805_CR73","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ejhf.196","volume":"17","author":"M Akpek","year":"2015","unstructured":"Akpek M, Ozdogru I, Sahin O, Inanc M, Dogan A, Yazici C, Berk V, Karaca H, Kalay N, Oguzhan A, Ergin A (2015) Protective effects of spironolactone against anthracycline-induced cardiomyopathy. Eur J Heart Fail 17:81\u201389","journal-title":"Eur J Heart Fail"},{"key":"9805_CR74","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1016\/j.jacc.2012.07.067","volume":"60","author":"S Seicean","year":"2012","unstructured":"Seicean S, Seicean A, Plana JC, Budd GT, Marwick TH (2012) Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: an observational clinical cohort study. J Am Coll Cardiol 60:2384\u20132390","journal-title":"J Am Coll Cardiol"},{"key":"9805_CR75","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cjca.2014.11.020","volume":"31","author":"R Chotenimitkhun","year":"2015","unstructured":"Chotenimitkhun R, D\u2019Agostino R Jr, Lawrence JA et al (2015) Chronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection function. Can J Cardiol 31:302\u2013307","journal-title":"Can J Cardiol"},{"key":"9805_CR76","doi-asserted-by":"publisher","first-page":"509","DOI":"10.5603\/CJ.a2013.0150","volume":"21","author":"A Elitok","year":"2014","unstructured":"Elitok A, Oz F, Cizgici AY, Kilic L, Ciftci R, Sen F, Bugra Z, Mercanoglu F, Oncul A, Oflaz H (2014) Effect of carvedilol on silent anthracycline-induced cardiotoxicity assessed by strain imaging: a prospective randomized controlled study with six-month follow-up. Cardiol J 21:509\u2013515","journal-title":"Cardiol J"},{"key":"9805_CR77","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.jacc.2018.02.049","volume":"71","author":"MS Avila","year":"2018","unstructured":"Avila MS, Ayub-Ferreira SM, de Barros Wanderley MR Jr et al (2018) Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY Trial. J Am Coll Cardiol 71:2281\u20132290","journal-title":"J Am Coll Cardiol"},{"key":"9805_CR78","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1001\/jamaoncol.2016.1726","volume":"2","author":"AH Boekhout","year":"2016","unstructured":"Boekhout AH, Gietema JA, Milojkovic Kerklaan B, van Werkhoven ED, Altena R, Honkoop A, Los M, Smit WM, Nieboer P, Smorenburg CH, Mandigers CMPW, van der Wouw AJ, Kessels L, van der Velden AWG, Ottevanger PB, Smilde T, de Boer J, van Veldhuisen DJ, Kema IP, de Vries EGE, Schellens JHM (2016) Angiotensin II-receptor inhibition with candesartan to prevent trastuzumab-related cardiotoxic effects in patients with early breast cancer: a randomized clinical trial. JAMA Oncol 2:1030\u20131037","journal-title":"JAMA Oncol"},{"key":"9805_CR79","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejca.2018.02.005","volume":"94","author":"D Cardinale","year":"2018","unstructured":"Cardinale D, Ciceri F, Latini R, Franzosi MG, Sandri MT, Civelli M, Cucchi GF, Menatti E, Mangiavacchi M, Cavina R, Barbieri E, Gori S, Colombo A, Curigliano G, Salvatici M, Rizzo A, Ghisoni F, Bianchi A, Falci C, Aquilina M, Rocca A, Monopoli A, Milandri C, Rossetti G, Bregni M, Sicuro M, Malossi A, Nassiacos D, Verusio C, Giordano M, Staszewsky L, Barlera S, Nicolis EB, Magnoli M, Masson S, Cipolla CM, Cipolla CM, Cardinale D, Ciceri F, Latini R, Sandri MT, Maggioni AP, Labianca R, Tettamanti M, Senni M, Finzi A, Grosso F, Vago T, Civelli M, Gramenzi S, Masson S, Balconi G, Bernasconi R, Salvatici M, Nicolis E, Barlera S, Magnoli M, Buratti MG, Ojeda Fernandez ML, Franzosi MG, Staszewsky L, Vasam\u00ec A, Malossi A, Sicuro M, Thiebat B, Bar\u00e8 C, Corzani A, Coccolo F, Colecchia S, Pellegrini C, Bregni M, Appio L, Caico I, G.Rossetti, Mesenzani O, Campana C, Giordano M, Gilardoni M, Scognamiglio G, Corrado G, Battagin D, de Rosa F, Carpino C, Palazzo S, Monopoli A, Milandri C, Giannessi PG, Zipoli G, Ghisoni F, Rizzo A, Pastori P, Callegari S, Sesenna C, Colombo A, G.Curigliano, Fodor C, Mangiavacchi M, Cavina R, Guiducci D, Mazza R, Turazza FM, Vallerio P, Marbello L, Sala E, Fragasso G, Trinca S, Aquilina M, Rocca A, Farolfi A, Andreis D, Gori S, Barbieri E, Lanzoni L, Marchetti F, Falci C, Bianchi A, Mioranza E, Banzato A, Re F, Gaibazzi N, Gullo M, Turina MC, Gervasi E, Giaroli F, Nassiacos D, Verusio C, Barco B, Bertolini A, Cucchi G, Menatti E, Sinagra G, Aleksova A, Guglielmi A, Pinotti G, Gueli R, Mongiardi C, Vallini I (2018) ICOS-ONE study investigators anthracycline-induced cardiotoxicity: a multicenter randomised trial comparing two strategies for guiding prevention with enalapril: the International CardioOncology Society-one trial. Eur J Cancer 94:126\u2013137","journal-title":"Eur J Cancer"},{"key":"9805_CR80","doi-asserted-by":"publisher","first-page":"vii155","DOI":"10.1093\/annonc\/mds293","volume":"23","author":"G Curigliano","year":"2012","unstructured":"Curigliano G, Cardinale D, Suter T et al (2012) Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol 23:vii155\u2013vii166","journal-title":"Ann Oncol"},{"key":"9805_CR81","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","volume":"55","author":"D Cardinale","year":"2010","unstructured":"Cardinale D, Colombo A, Lamantia G, Colombo N, Civelli M, de Giacomi G, Rubino M, Veglia F, Fiorentini C, Cipolla CM (2010) Anthracycline-induced cardiomyopathy. Clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol 55:213\u2013220","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09805-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-019-09805-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09805-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T17:36:31Z","timestamp":1663522591000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-019-09805-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,27]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["9805"],"URL":"https:\/\/doi.org\/10.1007\/s10741-019-09805-1","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,27]]},"assertion":[{"value":"27 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}